A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes

Value in Health

Volumn 17, Issue 5, 2014, Pages 561-569

  Ly, Trang T ^a,b,c   Brnabic, Alan J M ^d   Eggleston, Andrew ^e   Kolivos, Athena ^e   McBride, Margaret E ^e   Schrover, Rudolf ^f   Jones, Timothy W ^a,b,c  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d OPTUM   (United States)

^e Medtronic Australasia   (Australia)

^f PRIMA Consulting Group Pty Ltd   (Australia)

Author keywords

cost effectiveness; hypoglycemia; insulin pump therapy; type 1 diabetes

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; BLOOD GLUCOSE MONITORING; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENSOR;

COST-EFFECTIVENESS; HYPOGLYCEMIA; INSULIN PUMP THERAPY; TYPE 1 DIABETES;

AUSTRALIA; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; INSULIN INFUSION SYSTEMS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 84906260788     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2014.05.008     Document Type: Article

References (44)

1. NDSS Australia. Insulin Therapy. Available from: http://www.ndss.com.au/ Global/Data%20Snapshots/March%202014/NDSS-StatisticalSnapshot-Insulin- 31March2014.pdf. 2014. [Accessed June 11, 2014].
2. M.E. Craig, S.M. Twigg, and K.C. Donaghue et al. National Evidence-Based Clinical Care Guidelines for Type 1 Diabetes in Children, Adolescents and Adults 2011 Australian Government Department of Health and Ageing Canberra, Australia
3. N. Kedia Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach Diabetes Metab Syndr Obes 4 2011 337 346
4. Australian Institute of Health and Welfare Insulin Pump Use in Australia. Diabetes series number 18. Cat. no. CVD 58 2012 Australian Institute of Health and Welfare Canberra, Australia
5. J.C. Pickup, and A.J. Sutton Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion Diabet Med 25 2008 765 774
6. J.C. Pickup Insulin-pump therapy for type 1 diabetes mellitus N Engl J Med 366 2012 1616 1624
7. E.A. Northam, P.J. Anderson, and R. Jacobs et al. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset Diabetes Care 24 2001 1541 1546
8. J.F. Rovet, R.M. Ehrlich, and D. Czuchta Intellectual characteristics of diabetic children at diagnosis and one year later J Pediatr Psychol 15 1990 775 788
9. C. Ryan, A. Vega, and A. Drash Cognitive deficits in adolescents who developed diabetes early in life Pediatrics 75 1985 921 927
10. K. Barnard, S. Thomas, and P. Royle et al. Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review BMC Pediatr 10 2010 50
11. T.K. Mattila, and A. de Boer Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus Drugs 70 2010 2229 2245
12. T.T. Ly, P.H. Gallego, and E.A. Davis et al. Impaired awareness of hypoglycemia in a population-based sample of children and adolescents with type 1 diabetes Diabetes Care 32 2009 1802 1806
13. American Diabetes Association Standards of medical care in diabetes - 2013 Diabetes Care 36 Suppl. 1 2013 S11 S66
14. P.Y. Benhamou, B. Catargi, and B. Delenne et al. Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE Diabetes Metab 38 Suppl. 4 2012 S67 S83
15. T.T. Ly, J. Hewitt, and R.J. Davey et al. Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes Diabetes Care 34 2011 50 52
16. T.T. Ly, J.A. Nicholas, and A. Retterath et al. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial JAMA 310 2013 1240 1247
17. L. Mackowiak, D.A. Finan, and T.W. McCann et al. Feasibility study assessing Hypoglycaemia-Hyperglycaemia Minimiser (HHM) system in patients with type 1 diabetes in a Clinical Research Centre (CRC) Diabetologia 55 Suppl 2012 S434
18. L. Mackowiak, D.A. Finan, and T.W. McCann et al. Feasibility study assessing Hypoglycaemia-Hyperglycaemia Minimiser (HHM) system in patients with type 1 diabetes in a Clinical Research Centre (CRC) Diabetes 61 2012 A233
19. M. Holder, O. Kordonouri, and H. Haberland et al. The low glucose suspend function in sensor-augmented pump therapy prevents hypoglycaemia in children Diabetologia 54 Suppl 2011 S400
20. T. Danne, O. Kordonouri, and M. Holder et al. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy Diabetes Technol Ther 13 2011 1129 1134
21. P. Agrawal, J.B. Welsh, and B. Kannard et al. Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump J Diabetes Sci Technol 5 2011 1137 1141
22. E. Cengiz, K.L. Swan, and W.V. Tamborlane et al. Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system Diabetes Technol Ther 11 2009 207 210
23. W.L. Clarke, D.J. Cox, and L.A. Gonder-Frederick et al. Reduced awareness of hypoglycemia in adults with IDDM: a prospective study of hypoglycemic frequency and associated symptoms Diabetes Care 18 1995 517 522
24. D.K. Miller, and S.M. Homan Determining transition probabilities: confusion and suggestions Med Decis Making 14 1994 52 58
25. J. Lundkvist, C. Berne, and B. Bolinder et al. The economic and quality of life impact of hypoglycemia Eur J Health Econ 6 2005 197 202
26. EuroQol Group. EuroQol - EQ-5D-Y. Available from: http://www.euroqol.org/ eq-5d-products/eq-5d-y.html. [Accessed April 8, 2014].
27. A.R. Levy, T.L. Christensen, and J.A. Johnson Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom Health Qual Life Outcomes 6 2008 73
28. Australian Government Department of Health and Ageing. Pharmaceutical Benefits Scheme (PBS). Accessed from: http://www.pbs.gov.au/pbs/home. [Accessed June 11, 2014].
29. Australian Government Department of Health and Ageing. Private health insurance prostheses list. Accessed from: http://www.health.gov.au/internet/ main/publishing.nsf/Content/prostheses-list-pdf.htm. [Accessed August 23, 2013].
30. Private Health Insurance Administration Council. PHIAC A Australia September 2012. 2012. Available from: http://phiac.gov.au/industry/industry- statistics/quarterly-statistics/. [Accessed July 8, 2014].
31. Australian Government Department of Health. National hospital cost data collection. Cost report round 12 (2007-2008). Public Hospitals: A-DRG 5.1; Private Hospitals AR-DRG 5.1; Private Day Hospital Facilities: AR-DRG 5.1. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/ Round-12-cost-reports. [Accessed April 8, 2014].
32. Australian Government Department of Health and Ageing. Medical benefits schedule. Available from: http://www9.health.gov.au/mbs/search.cfm?pdf=yes. [Accessed April 8, 2014].
33. M. Hammer, M. Lammert, and S.M. Mejias et al. Costs of managing severe hypoglycaemia in three European countries J Med Econ 12 2009 281 290
34. G.P. Leese, J. Wang, and J. Broomhall et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use Diabetes Care 26 2003 1176 1180
35. Australian Government Department of Health and Ageing. Data collections - round 14 (2009-10) National public cost weight tables - version 6.0x and version 5.2. Available from: http://www.commcarelink.health.gov.au/internet/ main/publishing.nsf/Content/Round-14-cost-reports. [Accessed April 8, 2014].
36. N. Cohen, M.E. Minshall, and L. Sharon-Nash et al. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia Pharmacoeconomics 25 2007 881 897
37. E. Cummins, P. Royle, and A. Snaith et al. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation Health Technol Assess 14 2010 iii-iv, xi-xvi, 1-181
38. S. Kamble, K.P. Weinfurt, and K.A. Schulman et al. Patient time costs associated with sensor-augmented insulin pump therapy for type 1 diabetes: results from the STAR 3 randomized trial Med Decis Making 33 2013 215 224
39. C.J. Currie, C.L. Morgan, and C.D. Poole et al. Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes Curr Med Res Opin 22 2006 1523 1534
40. R.R. Rubin, and M. Peyrot Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump J Diabetes Sci Technol 3 2009 1402 1410
41. S.J. Logtenberg, N. Kleefstra, and S.T. Houweling et al. Health-related quality of life, treatment satisfaction, and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: a randomized controlled trial Diabetes Care 33 2010 1169 1172
42. R. Nuboer, G.J. Borsboom, and J.A. Zoethout et al. Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison Pediatr Diabetes 9 2008 291 296
43. C. Fidler, T. Elmelund Christensen, and S. Gillard Hypoglycemia: an overview of fear of hypoglycemia, quality-of-life, and impact on costs J Med Econ 14 2011 646 655
44. P. Choudhary Insulin pump therapy with automated insulin suspension: toward freedom from nocturnal hypoglycemia JAMA 310 2013 1235 1236